Cellectar Biosciences, Inc. — Director's Dealing 2019

Sep 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2019-09-10

Reporting Person: Elefant Dov (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-10	Stock Option (right to buy)	$2.32	A	90000	Acquired	2029-09-10	Common Stock (90000)	Direct

Footnotes

F1: Options vest in equal annual increments over a period of three years from the date of grant.